Callan Family Office LLC bought a new position in shares of Ambev S.A. (NYSE:ABEV - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 150,906 shares of the company's stock, valued at approximately $279,000.
Several other hedge funds and other institutional investors have also recently bought and sold shares of ABEV. MCIA Inc acquired a new position in shares of Ambev in the 3rd quarter worth approximately $25,000. Insight Inv LLC bought a new stake in Ambev during the fourth quarter valued at $25,000. Wealthstream Advisors Inc. acquired a new stake in Ambev during the 3rd quarter worth about $29,000. Exchange Traded Concepts LLC bought a new position in shares of Ambev in the 4th quarter worth about $30,000. Finally, Mesirow Financial Investment Management Inc. bought a new stake in Ambev in the third quarter worth approximately $35,000. 8.13% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
ABEV has been the subject of several recent analyst reports. Citigroup reaffirmed a "neutral" rating on shares of Ambev in a research report on Wednesday, January 22nd. Bank of America cut shares of Ambev from a "buy" rating to a "neutral" rating in a report on Friday, January 17th. StockNews.com initiated coverage on shares of Ambev in a report on Monday, January 27th. They set a "buy" rating on the stock. Finally, Barclays reduced their target price on Ambev from $2.50 to $2.00 and set an "equal weight" rating for the company in a research note on Tuesday, January 21st. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $2.45.
Get Our Latest Stock Report on Ambev
Ambev Stock Up 2.9 %
ABEV traded up $0.07 during trading on Friday, hitting $2.31. 52,517,776 shares of the company's stock were exchanged, compared to its average volume of 25,391,250. Ambev S.A. has a fifty-two week low of $1.76 and a fifty-two week high of $2.56. The stock has a market cap of $36.31 billion, a P/E ratio of 12.81, a PEG ratio of 5.80 and a beta of 0.94. The business's 50 day moving average is $1.92 and its two-hundred day moving average is $2.12. The company has a quick ratio of 0.89, a current ratio of 1.20 and a debt-to-equity ratio of 0.02.
Ambev (NYSE:ABEV - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.05 earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by ($0.01). The business had revenue of $4.63 billion during the quarter, compared to analyst estimates of $22.42 billion. Ambev had a return on equity of 16.12% and a net margin of 17.02%. As a group, equities analysts expect that Ambev S.A. will post 0.18 earnings per share for the current fiscal year.
Ambev Cuts Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, April 14th. Shareholders of record on Tuesday, March 18th will be paid a $0.0221 dividend. The ex-dividend date of this dividend is Tuesday, March 18th. This represents a $0.09 annualized dividend and a yield of 3.83%. Ambev's dividend payout ratio (DPR) is 52.94%.
Ambev Profile
(
Free Report)
Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.
Further Reading

Before you consider Ambev, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.
While Ambev currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.